Skip to main content
. 2022 Jan 4;2022:9455428. doi: 10.1155/2022/9455428

Table 1.

Comparison of clinical characteristics of patients in each group.

Characteristics Control group (n = 60) NMES group (n = 60) rTMS group (n = 60) NMES+rTMS group (n = 60) X 2/F P
Age (year) 57.2 ± 8.95 58.77 ± 8.39 59.05 ± 8.9 58.22 ± 9.98 0.485 0.693
Gender (%) 1.735 0.629
 Male 34 (56.7) 28 (46.7) 33 (55) 29 (48.3)
 Female 26 (43.3) 32 (53.3) 27 (45) 31 (51.7)
BMI (kg/m2) 23.87 ± 3.09 23.91 ± 3.37 24.15 ± 3.3 23.8 ± 3.43 0.129 0.943
Disease course (month) 47.02 ± 14.21 50.25 ± 11.78 45.95 ± 12.73 47.7 ± 12.37 1.224 0.302
Dominant hand (%) 2.459 0.483
 Left 6 (10) 3 (5) 2 (3.3) 4 (6.7)
 Right 54 (90) 57 (95) 58 (96.7) 56 (93.3)
Stroke type (%) 3.055 0.383
 ICH 14 (23.3) 20 (33.3) 12 (20) 15 (25)
 IS 46 (76.7) 40 (66.7) 48 (80) 45 (75)
Hemiplegic direction (%) 1.765 0.623
 Left 34 (56.7) 35 (58.3) 37 (61.7) 30 (50)
 Right 26 (43.3) 25 (41.7) 23 (38.3) 30 (50)
Brunstrom stage (%) 2.705 0.997
 II stage 23 (38.3) 21 (35) 21 (35) 20 (33.3)
 III stage 15 (25) 16 (26.7) 18 (30) 21 (35)
 IV stage 10 (16.7) 10 (16.7) 8 (13.3) 8 (13.3)
 V stage 8 (13.3) 9 (15) 8 (13.3) 6 (10.0)
 VI stage 4 (6.7) 4 (6.7) 5 (8.3) 5 (8.3)